Navigation Links
EDAP Launches Enhanced Communication Plans at SIU Paris Congress
Date:9/10/2007

Ablatherm-HIFU Marketing Programs Help Surgeons Go the Extra Mile for

Patients

Ablatherm-HIFU Strong Clinical Outcomes Confirmed

LYON, France, Sept. 10 /PRNewswire-FirstCall/ -- EDAP TMS S.A. (Nasdaq: EDAP), the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer and a major global provider of stone breaking products, launched its newly enhanced communication and education programs for Ablatherm-HIFU and its stone breaking products at the Societe Internationale d'Urologie (SIU) Congress in Paris running September 3-5, 2007, gathering more than 3,000 urologists and surgeons. SIU is a complementary event to renowned American Urology Association (AUA) and European Association of Urology (EAU). SIU though is the only truly international professional organization for urology and publishes the journal "Urologie" in which EDAP has previously presented groundbreaking HIFU research in treatment of localized prostate cancer.

EDAP was actively present at SIU to consolidate contacts with emerging non-European or US markets where interest for the company's products and technology is increasing. EDAP's booth presence highlighted Ablatherm(R)-HIFU as well as the company's new high-end Sonolith(R) I-sys product and the associated distributed intracorporeal LMA Stonebreaker(R) device.

The company has fielded numerous inquiries about its highly acclaimed and anticipated Sonolith I-sys lithotripsy unit, a new high-end device for kidney stone treatment. The I-sys answers market demand for top-of-the-line lithotripsy products with all the features and brings EDAP back to the forefront in lithotripsy technology. Hosted visits for customers will begin in Lyon in October at HEH, one of Europe's premier urology hospitals and a major EDAP research center. The new marketing and communication program was officially launched at the SIU providing the urologists with newly designed very
'/>"/>

SOURCE EDAP TMS S.A.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Pfizer Launches Viagra For Lung Disease In UK
8. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Kinase Inhibitors: Global Markets ,...Inhibitors-Global-Markets.html ,, Forecasts ...s 2005 through 2008, and projections for the marke... 2014 ,, An overview of the market for the kin...
(Date:12/2/2009)...e-USNewswire/ -- ,, Statement by John Gay, Exe...ion ,, In response to a new campaign launched...ducate consumers and rid the marketplace of "rogue...s, the Natural Products Association, the oldest an... and manufacturers of dietary supplements and othe...
(Date:12/2/2009)...e sleep disturbances, study finds , , WE...d club drug ecstasy appears to increase the risk o...who use ecstasy need to know that this drug damage...problems such as sleep apnea," study author Dr. Un...in Baltimore, said in a news release. , McCann ...
(Date:12/2/2009)... By now, most people have heard of...nue to grow in popularity. And, the latest product...arette - the new single piece PremiumOne(TM) dispo...price of $14.99. ,, "This new product makes it ...ry low price, before making a bigger investment in...
(Date:12/2/2009)...2 Care Support of America,s mode...anced Illness Coordinated Care (AICC) , has been s...of life as well as improve the quality of life for...asing mortality. These are the principal findings ...anaged Care (November 2009). ,, Based on a...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 3Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 4Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 5Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 6Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 7Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 8Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 9Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 10Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 11Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 12Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 14Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 15Health News:Natural Products Association Issues Statement on New Supplement Safety Campaign 2Health News:Ecstasy Users at Higher Risk of Sleep Apnea 2Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 4
...s all over between Kate Moss and Pete Doherty afte...odel , it seems that the waifish beauty will still...t. The implant will be the fifth one for t...nderstands that Doherty needs help and will not le...
...ore than 90 per cent of women undergoing fertility...ility drugs meant to stimulate their ovaries . ...at the drugs may not work properly, but also that ...r increased during IVF, by giving them drugs. The ...
...as been named the most vegan-friendly food chain b...he animal rights group for its cheese-free pizzas,... of the 20 organisations recognised by PETA for 'a... with a pizza oven and chef imported from Italy. ...
...etox 5 in North Yorkshire, troubled rocker Pete Do...his time for littering . The Babysh...ed by the police as soon as they spotted him chuck...ed, and that the police gave him a stern warning a...
...te of Technology (MIT) are working towards constru...le allowing astronauts superior mobility when the... Since Yuri Gagarins time spacesuits have seen sca...t restrict mobility. Now, Dava N...
...out their problems with their pals, for a new stud... risk of developing anxiety and depression . ...al sciences in the College of Arts and Science con...nts - boys and girls - examined the effects of co-...
Other Medicine News:Health News:Spacesuits of the Future Will Be as Flexible as Spidermans 2Health News:Complaining Girls Faces Higher Depression, Anxiety Risk 2
(Date:12/2/2009)...c. 2 Cardinal Health tod...pany,s board of directors, effective immediately. ...ice president and president of global pharmaceutic...ure with the company at the close of its merger wi...chering-Plough, Cox served as president of Pharmac...
(Date:12/2/2009)...LUND, Sweden, December 2 DermaGen ...y and wound healing company "Pergamum" -,today ann...ults from a,clinical Phase I/IIa study. DermaGen A...) treatment for atopic dermatitis. Atopic dermatit...y skin and the skin,s weakened barrier,function ma...
(Date:12/2/2009)... Isreal, December 2 Card...ing developer of advanced,cardiovascular surgery t...d,of Directors approved a one-for-three forward st...e to Cardio Vascular Medical Device shareholders. ... the estimated date the stock,split will be payabl...
Breaking Medicine Technology:Cardinal Health Names Carrie Cox to Board of Directors 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4Cardio Vascular Medical Device Announces Forward Stock Split 2Mini Strokes May Cause Vision Loss 50874 1Mini Strokes May Cause Vision Loss 50874 2Mini Strokes May Cause Vision Loss 50874 3Blue Cross and Blue Shield of Florida Expands Low Cost BlueSelect Health Plan to Five Florida Counties 50873 1Blue Cross and Blue Shield of Florida Expands Low Cost BlueSelect Health Plan to Five Florida Counties 50873 2ArborGen and Senesco Announce Wood Quality Results 12911 1ArborGen and Senesco Announce Wood Quality Results 12911 2ArborGen and Senesco Announce Wood Quality Results 12911 3ArborGen and Senesco Announce Wood Quality Results 12911 4
...IEW, Calif., June 22, 2007 /PRNewswire/ -- MAP,Pha...esent Phase 2,data from its Unit Dose Budesonide (...the World Asthma Meeting at the Lutfi Kirdar,Conve... The oral and poster presentation entitled, "Effic...lation of budesonide for,nebulized delivery in a 6...
...June 22, 2007 /PRNewswire-FirstCall/ -- Keryx,Biop...s related to,Sulonex(TM) (sulodexide oral gelcap) ... during the poster sessions scheduled to,take plac...DA) 67th,Annual Scientific Sessions and exposition..., Illinois. , Copies of these abstracts, which hig...
Other Medicine Technology:MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois 4
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: